Research programme: BK potassium channel modulators - NeuroSearch/TopoTarget

Drug Profile

Research programme: BK potassium channel modulators - NeuroSearch/TopoTarget

Alternative Names: NSD-551

Latest Information Update: 27 Aug 2007

Price : $50

At a glance

  • Originator NeuroSearch
  • Developer NeuroSearch; TopoTarget
  • Class
  • Mechanism of Action Potassium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Brain cancer

Most Recent Events

  • 22 Aug 2007 Discontinued - Preclinical for Brain cancer in Denmark (unspecified route)
  • 14 May 2007 Preclinical development is ongoing
  • 30 Aug 2005 NeuroSearch and TopoTarget have entered into an agreement to co-develop and co-promote NSD 551
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top